In order to verify whether lactate metabolism was involved in these effects on GBM cell proliferation and migration, we analyzed the effect of the MCT1 inhibitor (AZD3965, 10 μM) and the HCAR1 antagonist (3-OBA, 3 mM). This evidence concerns the gene HCAR1 and glioblastoma.